Elizabeth Stenger

1.1k total citations
37 papers, 470 citations indexed

About

Elizabeth Stenger is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Elizabeth Stenger has authored 37 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 15 papers in Hematology and 11 papers in Immunology. Recurrent topics in Elizabeth Stenger's work include Hemoglobinopathies and Related Disorders (15 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Prenatal Screening and Diagnostics (7 papers). Elizabeth Stenger is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Prenatal Screening and Diagnostics (7 papers). Elizabeth Stenger collaborates with scholars based in United States, Canada and South Africa. Elizabeth Stenger's co-authors include Hēth Turnquist, Angus W. Thomson, Markus Y. Mapara, Michael J. Hannon, C. Kent Kwoh, Paul Rosen, Matthew Bochkoris, Lakshmanan Krishnamurti, Shalini Shenoy and Jacques Galipeau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

Elizabeth Stenger

32 papers receiving 459 citations

Peers

Countries citing papers authored by Elizabeth Stenger

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Stenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Stenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Stenger more than expected).

Fields of papers citing papers by Elizabeth Stenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Stenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Stenger. The network helps show where Elizabeth Stenger may publish in the future.

Co-authorship network of co-authors of Elizabeth Stenger

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Stenger. A scholar is included among the top collaborators of Elizabeth Stenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Stenger. Elizabeth Stenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis 2025 ·Blood ·Elizabeth Stenger, Ruta Brazauskas, Andrew C. Peterson, (unknown), Minoo Battiwalla, David Buchbinder, Betty K. Hamilton, Bipin N. Savani, Hélène Schoemans, Michelle Long Schoettler, Mohamed L. Sorror, Rachel Phelan, Shalini Shenoy, Lakshmanan Krishnamurti	0
2	Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis 2024 ·British Journal of Haematology ·Michelle Long Schoettler, Adrianna Westbrook, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Kirsten M. Williams	1
3	Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation 2024 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), (unknown), Elizabeth Stenger, Staci D. Arnold, Akanksha Mehta, (unknown), Jessica B. Spencer, Gregory M.T. Guilcher, Monica Bhatia, Allistair Abraham, Veronica Gomez‐Lobo, Lakshmanan Krishnamurti, Lillian R. Meacham	0
4	D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study 2024 ·American Journal of Hematology ·Michelle Long Schoettler, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shanmuganathan Chandrakasan, Suhag Parikh, Benjamin Watkins, Elizabeth Stenger, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Jeffrey M. Switchenko, Kirsten M. Williams	7
5	Rheological Comparison of Red Cells from Individuals with SCD Treated with Gene Therapy, Haploidentical Transplantation or Hydroxyurea 2024 ·Blood ·(unknown), (unknown), (unknown), (unknown), Stephen Gottschalk, Brandon M. Triplett, Serena De Vita, (unknown), David C. Shyr, Elizabeth Stenger, Suhag Parikh, Akshay Sharma, Vivien Sheehan	1
6	Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children 2024 ·Transplantation and Cellular Therapy ·Michelle Long Schoettler, (unknown), (unknown), (unknown), Muna Qayed, Elizabeth Stenger, (unknown), Satheesh Chonat, Adrianna Westbrook, Kirsten M. Williams	1
7	Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning? 2023 ·Transplantation and Cellular Therapy ·Lillian R. Meacham, (unknown), (unknown), (unknown), Ann E. Haight, Staci D. Arnold, (unknown), Elizabeth Stenger, Lakshmanan Krishnamurti	9
8	Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor—Case report and review of the literature 2023 ·Pediatric Blood & Cancer ·Catherine Hughes, (unknown), Benjamin Watkins, Muna Qayed, Suhag Parikh, Edwin M. Horwitz, Elizabeth Stenger, Kirsten M. Williams, Michelle Long Schoettler	1
9	Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure 2023 ·Blood Advances ·Elizabeth Stenger, Benjamin Watkins, (unknown), Kuang‐Yueh Chiang, Ann E. Haight, Kathryn Leung, Muna Qayed, (unknown), Yvonne Suessmuth, Leslie S. Kean, John Horan	12
10	Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·(unknown), Mehgan Teherani, (unknown), (unknown), Shanmuganathan Chandrakasan, (unknown), Ann E. Haight, Edwin M. Horwitz, (unknown), Suhag Parikh, Michelle Long Schoettler, (unknown), Elizabeth Stenger, Benjamin Watkins, Kirsten M. Williams, Wing Leung, Preeti Jaggi, Muna Qayed	1
11	Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study 2022 ·Transplantation and Cellular Therapy ·Elizabeth Stenger, Deepak Chellapandian, (unknown), (unknown), (unknown), Monica Bhatia, Sonali Chaudhury, Michael J. Eckrich, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, (unknown), (unknown), Tim S. Olson, Hemalatha G. Rangarajan, John Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham	1
12	Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children 2022 ·Blood Advances ·Michelle Long Schoettler, Elizabeth Stenger, (unknown), (unknown), (unknown), (unknown), Ann E. Haight, Suhag Parikh, Muna Qayed, Benjamin Watkins, Lakshmanan Krishnamurti, Kirsten M. Williams, Satheesh Chonat	9
13	Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease 2022 ·Frontiers in Immunology ·Elizabeth Stenger, Cynthia R. Giver, Amelia Langston, Daniel J. Kota, (unknown), Raghavan Chinnadurai, Jacques Galipeau, Edmund K. Waller, Muna Qayed	11
14	Conditioning Regimen Trends in Hematopoietic Stem Cell Transplant for Sickle Cell Disease: A Survey from the Sickle Cell Transplant Advocacy and Research Alliance (STAR) Consortium 2021 ·Transplantation and Cellular Therapy ·(unknown), Elizabeth Stenger, Scott Gillespie, Emily Riehm Meier, Gregory M.T. Guilcher, John Horan	0
15	Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies 2018 ·Blood ·Carl E. Allen, Rebecca Marsh, Peter Dawson, Catherine M. Bollard, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Lauri M. Burroughs, Leslie S. Kean, Julie‐An Talano, Kirk R. Schultz, Sung‐Yun Pai, K. Scott Baker, Jeffrey R. Andolina, Elizabeth Stenger, James A. Connelly, (unknown), Christopher Bryant, Mary Eapen, Michael A. Pulsipher	61
16	Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation 2017 ·Blood ·Elizabeth Stenger, (unknown), Diana Ross, Lillian R. Meacham, Courtney McCracken, Ann E. Haight, Lakshmanan Krishnamurti	1
17	Bone Marrow–Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality 2017 ·Biology of Blood and Marrow Transplantation ·Elizabeth Stenger, Raghavan Chinnadurai, Shala Yuan, Marco Garcia, Dalia Arafat, Greg Gibson, Lakshmanan Krishnamurti, Jacques Galipeau	10
18	Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases 2015 ·Biology of Blood and Marrow Transplantation ·Elizabeth Stenger, Kuang‐Yueh Chiang, Ann E. Haight, Muna Qayed, Leslie S. Kean, John Horan	4
19	Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation 2015 ·BMC Immunology ·Elizabeth Stenger, Lakshmanan Krishnamurti, Jacques Galipeau	8
20	IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ–Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-Versus-Host Disease 2013 ·Biology of Blood and Marrow Transplantation ·Elizabeth Stenger, Brian Rosborough, Lisa Mathews, Huihui Ma, Markus Y. Mapara, Angus W. Thomson, Hēth Turnquist	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact